An NHS GP has shared that ovarian cancer 'worries' her the most because the symptoms are so obscure – as she said everyone ...

That’s when the same type of cancer comes back after you have completed treatment and gone into remission. But some cancers, such as ovarian cancer, also raise your risk for developing a ...

Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian cancer and liver metastases (OCLM), outperforming an external model in ...

1 Experimental Therapeutics, British Columbia Cancer Agency Cancer Research Centre, Vancouver, BC, Canada 2 OVCARE ... of ovarian cancer as a collection of disease, only a handful of large type ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

In patients with early-stage ovarian cancer, a high prognostic nutritional index improved survival, while a high systemic immune-inflammation index worsened it. In advanced stages, both affected ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

The one-year PFS rate was 75.2%, with a median PFS of 21.0 months ... remission in patients with HRD-positive, BRCA wild-type ovarian cancer. The safety profile of olaparib was consistent with ...

The 1-year PFS rate was 75.2%, with a median PFS of 21.0 months ... remission in patients with HRD-positive, BRCA wild-type ovarian cancer. The safety profile of olaparib was consistent with ...

Ovarian cancer continues to pose a significant challenge in the medical field, remaining one of the leading causes of death ...